Demonstration of insulin degradation by thiol-protein disulfide oxidoreductase (glutathione-insulin transhydrogenase) and proteinases of pancreatic islets
- PMID: 174741
- DOI: 10.1016/0005-2744(76)90136-4
Demonstration of insulin degradation by thiol-protein disulfide oxidoreductase (glutathione-insulin transhydrogenase) and proteinases of pancreatic islets
Abstract
Homogenate preparations of pancreatic islets have been found to degrade insulin by cleavage of the interchain disulfide bonds, followed by proteolysis of the resulting A and B chains. A proteolytic system of the pancreatic islets splitting not only 125I-labeled insulin A chain but also 125I-labeled glucagon at pH 7.0, was shown to be activated by glutathione and inhibited by EDTA. The results suggest that pancreatic islets contain both the thiol-protein disulfide oxidoreductase (glutathione : protein-disulfide oxidoreductase, EC 1.8.4.2) and the A and B chain-degrading enzyme(s). The effects of EDTA argue against the implication of cathepsins in insulin breakdown under the experimental conditions employed.
Similar articles
-
Proteolytic and transhydrogenolytic activities in isolated pancreatic islets of rats.Acta Biol Med Ger. 1977;36(11-12):1695-703. Acta Biol Med Ger. 1977. PMID: 358709
-
Thiol-protein disulfide oxidoreductase and peptidase activities in insulinoma tissue.Biomed Biochim Acta. 1983;42(9):1091-101. Biomed Biochim Acta. 1983. PMID: 6322744
-
The immunochemical identification of a thiol-protein disulfide oxidoreductase (glutathione-insulin transhydrogenase) in pancreatic islets.Mol Cell Endocrinol. 1981 Jun;22(3):305-13. doi: 10.1016/0303-7207(81)90039-3. Mol Cell Endocrinol. 1981. PMID: 6788621
-
Insulin degradation: mechanisms, products, and significance.Endocr Rev. 1988 Aug;9(3):319-45. doi: 10.1210/edrv-9-3-319. Endocr Rev. 1988. PMID: 3061785 Review.
-
Insulin metabolism and degradation.Endocr Rev. 1981 Spring;2(2):210-33. doi: 10.1210/edrv-2-2-210. Endocr Rev. 1981. PMID: 7028472 Review. No abstract available.
Cited by
-
Interferon-α promotes neo-antigen formation and preferential HLA-B-restricted antigen presentation in pancreatic β-cells.bioRxiv [Preprint]. 2023 Sep 17:2023.09.15.557918. doi: 10.1101/2023.09.15.557918. bioRxiv. 2023. PMID: 37745505 Free PMC article. Preprint.
-
The insulin factory: a tour of the plant surroundings and a visit to the assembly line. The Minkowski lecture 1973 revisited.Diabetologia. 1985 Aug;28(8):528-46. doi: 10.1007/BF00281987. Diabetologia. 1985. PMID: 3902543 No abstract available.
-
Interferon-α promotes HLA-B-restricted presentation of conventional and alternative antigens in human pancreatic β-cells.Nat Commun. 2025 Jan 17;16(1):765. doi: 10.1038/s41467-025-55908-9. Nat Commun. 2025. PMID: 39824805 Free PMC article.
-
Islet amyloid in Type 2 (non-insulin-dependent) diabetes is related to insulin.Diabetologia. 1983 May;24(5):342-6. doi: 10.1007/BF00251821. Diabetologia. 1983. PMID: 6347781
-
Proinsulin modified by analogues of arginine and lysine is degraded rapidly in pancreatic B-cells.Biochem J. 1984 Apr 1;219(1):91-7. doi: 10.1042/bj2190091. Biochem J. 1984. PMID: 6372788 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources